SCHEMBL6169500

SCHEMBL6169500

CCOC(=O)C(OC(C)=O)(C(=O)OCC)c1c(C(=O)c2ccc(Cl)cc2)[nH]c2ccc(C)cc12

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.44
GAA P10253 2/20 0.44
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 2/20 0.44
NPC1 O15118 1/20 0.44
TP53 P04637 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TSHR P16473 1/20 0.41
CYP1A2 P05177 1/20 0.40
HPGD P15428 1/20 0.40
XBP1 P17861 1/20 0.40
CYP2C19 P33261 1/20 0.40
ALOX15 P16050 6/20 0.40
KMT2A Q03164 1/20 0.38
ALOX5 P09917 2/20 0.38
CSF1R P07333 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6171751 0.94 ALDH1A1 (0.46) MAPTGAAALDH1A1KDM4ESMN1; SMN2
SCHEMBL6169784 0.90 ALOX15 (0.39) MAPTALDH1A1KDM4ESMN1; SMN2CYP1A2
SCHEMBL6168269 0.88 ALOX15 (0.49) ALOX15
SCHEMBL6172685 0.88 ALOX15 (0.51) ALOX15
SCHEMBL6170441 0.87 ALDH1A1 (0.45) MAPTGAAALDH1A1KDM4ENPC1
SCHEMBL6168370 0.85 ALDH1A1 (0.46) MAPTGAAALDH1A1SMN1; SMN2CYP1A2
SCHEMBL6170937 0.83 ALOX15 (0.48) ALOX15
SCHEMBL6172675 0.83 ALOX15 (0.41) ALOX15
SCHEMBL6171200 0.82 ALOX15 (0.50) ALOX15
SCHEMBL6171092 0.82 ALOX15 (0.49) ALDH1A1CYP1A2HPGDXBP1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 EP disclosed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US disclosed
EP-1045833-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER INC. (US) 2000-10-25 EP disclosed
WO-1999035130-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER PHARMACEUTICALS INC. (JP) 1999-07-15 WO disclosed